What is the best course of treatment for a smoker with chronic elevated red blood cell (RBC) count, hemoglobin, hematocrit, and red cell distribution width (RDW)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Your Blood Test Results as a Smoker

Your elevated red blood cell count, hemoglobin, hematocrit, and RDW are directly caused by smoking—specifically from carbon monoxide exposure—and the single most important treatment is complete smoking cessation, which will begin reversing these abnormalities within 2 weeks. 1, 2

What's Happening in Your Blood

Your smoking is causing your body to produce extra red blood cells because:

  • Carbon monoxide from cigarette smoke binds to your hemoglobin (the oxygen-carrying protein in red blood cells), creating carboxyhemoglobin that can't carry oxygen effectively 1
  • Your body compensates by making more red blood cells to try to deliver adequate oxygen to your tissues 1
  • This creates a condition called "smokers' polycythemia"—essentially your blood becomes thicker and more viscous 1, 3
  • The elevated RDW (red cell distribution width) indicates your red blood cells vary more in size than normal, another direct effect of chronic smoking 4

Why This Matters for Your Health

This isn't just an abnormal lab value—it significantly increases your risk of serious health problems:

  • Cardiovascular disease risk including heart attack and stroke, because thicker blood flows less efficiently and increases clotting risk 3, 5
  • Symptoms you may be experiencing include fatigue, headaches, and potentially even fainting episodes 1
  • Your cardiovascular disease mortality risk remains elevated for 10-14 years after quitting (HR 1.20), emphasizing the urgency of stopping now 6

The Treatment Plan: Smoking Cessation

Immediate Action Required

You must stop smoking completely—there is no safe level of continued smoking that will resolve these blood abnormalities. 7, 8

  • Smoking cessation reduces stroke recurrence risk by 36% and is the single most important modifiable intervention for cardiovascular prevention 8
  • The health benefits of quitting far outweigh any theoretical medication risks, with a 25-50% reduction in mortality after cardiovascular events 8

What Happens When You Quit

The good news: these blood abnormalities begin reversing rapidly:

  • Within 2 weeks of quitting, your hemoglobin, hematocrit, red blood cell count, and white blood cell count will start returning toward normal 2
  • These changes indicate that the abnormalities are an acute, reversible effect of smoking rather than permanent tissue damage 2
  • Your blood carboxyhemoglobin levels (currently likely around 11.6% versus normal <1%) will normalize 1

Recommended Smoking Cessation Strategy

Use combination pharmacotherapy with behavioral counseling for the highest success rates: 7, 8

Primary treatment options (choose one):

  1. Combination nicotine replacement therapy (NRT): 21 mg nicotine patch daily PLUS short-acting NRT (gum, lozenge, inhaler, or nasal spray) for cravings—achieves 31.5% cessation rate and is explicitly safe even with cardiovascular disease 7, 8

  2. Varenicline: Start 1-2 weeks before your quit date with this dosing schedule 7:

    • Days 1-3: 0.5 mg once daily
    • Days 4-7: 0.5 mg twice daily
    • Weeks 2-12: 1 mg twice daily
    • Achieves 28% cessation rate and increases cessation 2-3 fold compared to unassisted attempts 8

Continue treatment for minimum 12 weeks, with possible extension to 6-12 months to maintain cessation 7

Behavioral Support Structure

Structured counseling significantly improves success rates: 7, 8

  • Schedule follow-up within 2 weeks of starting cessation treatment 7, 8
  • Continue monthly contact for at least 4 months 8
  • Use the "Five A's" approach: ASK about smoking status, ADVISE on quitting importance, ASSESS readiness, ASSIST with quit date and pharmacotherapy, ARRANGE follow-up 8
  • Consider referral to smoking cessation quitline or specialist if face-to-face counseling unavailable 7

Additional Cardiovascular Risk Management

While smoking cessation is paramount, you also need comprehensive cardiovascular risk reduction: 6

Blood Pressure Control

  • Target blood pressure <130/80 mmHg 6
  • Initiate lifestyle modifications: weight control, physical activity, alcohol moderation, sodium reduction, increased fruits/vegetables/low-fat dairy 7

Cholesterol Management

  • Check fasting lipid panel 6
  • If age ≥50 years or LDL-C ≥190 mg/dL, initiate statin therapy targeting LDL-C <55 mg/dL with ≥50% reduction from baseline 6

Lifestyle Modifications

  • Physical activity: 30-60 minutes of moderate activity >5 days per week 6
  • Diet: Mediterranean diet pattern high in vegetables, fruits, whole grains; limit saturated fat to <10% of total calories 6
  • Weight: Achieve BMI 18.5-25 kg/m² 6
  • Alcohol: Limit to <100 g/week 6

Follow-Up Monitoring Plan

Track your progress with these specific timepoints:

  • 2 weeks after quitting: Follow-up visit or phone call to assess cessation success and manage any withdrawal symptoms 7, 8
  • 3 months: Repeat complete blood count to document improvement in hemoglobin, hematocrit, RBC count, and RDW 6
  • 12 weeks: Complete initial pharmacotherapy course (may extend if needed) 7
  • Annually: Monitor cardiovascular risk factors including blood pressure, lipids, glucose/HbA1c, and weight 6

Critical Pitfalls to Avoid

  • Don't assume reducing cigarettes is sufficient—only complete cessation will fully reverse these blood abnormalities, though even reduction provides temporary benefit 5
  • Don't fear nicotine replacement therapy—blood nicotine levels from NRT are significantly less than from smoking, and NRT is well-tolerated even with cardiovascular disease 7
  • Don't delay starting treatment—your cardiovascular risk remains elevated for over a decade after quitting, so every day of continued smoking matters 6
  • Don't quit pharmacotherapy too early—nicotine withdrawal symptoms peak within 1-2 weeks but continuing therapy through 12 weeks significantly improves long-term success 7

References

Research

Smokers' polycythemia.

The New England journal of medicine, 1978

Research

Acute changes in haematological parameters on cessation of smoking.

Journal of the Royal Society of Medicine, 1992

Research

Effect of Cigarette Smoking on Haematological Parameters in Healthy Population.

Medical archives (Sarajevo, Bosnia and Herzegovina), 2017

Research

Relationship between tobacco smoking and hematological indices among Sudanese smokers.

Journal of health, population, and nutrition, 2024

Guideline

Management of Elevated MPV in Former Smokers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Smoking Cessation After CVA/TIA

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management approach for elevated hematocrit in smokers?
What does it mean for my health to have normal RBC, Hgb, and Hct levels as a smoker?
How does smoking cigarettes affect hemoglobin (Hb) levels?
Can smoking alone cause polycythemia with elevated Hemoglobin (Hgb) and Hematocrit (Hct) levels?
What is the management for elevated hematocrit (hyper viscosity) in smokers?
What is the normal thickness of the endometrium lining in a female patient of reproductive age with no known medical history or risk factors?
What is the appropriate diagnostic workup and management for a patient over 50 years old with a pancreatic head mass, abdominal pain, and potential risk factors for pancreatic cancer, such as smoking or a family history of the disease?
Is a posterior pedicle decompression of L5-S1, with bilateral lateral recess decompression, bilateral foraminotomies, and bilateral discectomy at the L5-S1 level, medically necessary for a patient with no documented cauda equina or spinal cord compression, lumbar radiculopathy, lumbar spondylolisthesis, pre-procedure signs and symptoms, physical examination findings, or failed conservative therapy, and is a 1-day inpatient admission medically necessary for this ambulatory procedure?
What is the recommended dosage of Phenazopyridine (urinary analgesic) for adults and adolescents with urinary tract infections, considering potential renal impairment?
What is the role of Immunoglobulin A (IgA), Immunoglobulin G (IgG), and Immunoglobulin M (IgM) quantification in the diagnosis, prognosis, and monitoring of multiple myeloma?
What are the treatment options for a patient experiencing Hypnos-related headaches?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.